The Elective Rotation - A Critical Care Pharmacy Podcast https://pharmacyjoe.com/podcast/the-elective-rotation-podcast/677-is-there-an-efficacy-tradeoff-when-reducing-apixaban-dose-in-patients-with-end-stage-renal-disease/ Mon, 10 Jan 2022 07:59:31 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 © 2025 Pharmacy Joe's Critical Care Resources Critical Care Pharmacy Resources From A Board Certified Pharmacotherapy Specialist Pharmacy Joe The Elective Rotation - the number 1 ranked Hospital Pharmacy podcast - is created for YOU Pharmacy Nation! If you are a Pharmacy Student, Resident, Pharmacist, Nurse, Physician, or Critical Care Practitioner in a hospital, intensive care unit (ICU) or emergency department looking to improve your practice, The Elective Rotation delivers unbiased critical care and hospital pharmacy content from a Board Certified Pharmacotherapy Specialist. Episodes are published every Monday and Thursday at 3AM EST. Find the show notes at pharmacyjoe.com. Pharmacy Joe joe@pharmacyjoe.com No 677: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease? https://pharmacyjoe.com/podcast/the-elective-rotation-podcast/677-is-there-an-efficacy-tradeoff-when-reducing-apixaban-dose-in-patients-with-end-stage-renal-disease/ https://pharmacyjoe.com/podcast/the-elective-rotation-podcast/677-is-there-an-efficacy-tradeoff-when-reducing-apixaban-dose-in-patients-with-end-stage-renal-disease/#respond Mon, 10 Jan 2022 08:00:40 +0000 https://joseph-muench-live.prev05.rmkr.net/?post_type=podcast&p=188971 Show notes at pharmacyjoe.com/episode677.

In this episode, I’ll discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease.

]]> https://pharmacyjoe.com/podcast/the-elective-rotation-podcast/677-is-there-an-efficacy-tradeoff-when-reducing-apixaban-dose-in-patients-with-end-stage-renal-disease/feed/ 0 Show notes at pharmacyjoe.com/episode677. In this episode, I’ll discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease. No No 3:07 Pharmacy Joe